Exome sequencing of Saudi Arabian patients with ADPKD
Purpose: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive development of kidney cysts and enlargement and dysfunction of the kidneys. The Consortium of Radiologic Imaging Studies of the Polycystic Kidney Disease (CRISP)
Fahad A. Al-Muhanna +19 more
doaj +2 more sources
Characterization of Primary Cilia in Osteoblasts Isolated From Patients With ADPKD and CKD [PDF]
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited cause of chronic kidney disease (CKD) and leads to a specific type of bone disease.
Renata C Pereira +6 more
doaj +2 more sources
SGLT2 inhibition for patients with ADPKD – closing the evidence gap
Inhibitors of the sodium-glucose cotransporter 2 (SGLT2i) were originally developed to treat diabetes mellitus but have shown important renoprotective benefits independently from blood glucose levels.
R. Müller +6 more
semanticscholar +2 more sources
Polycystins, ADPKD, and Cardiovascular Disease
Cardiovascular disorders are the most common cause of mortality in autosomal dominant polycystic kidney disease (ADPKD). This review considers recent clinical and basic science studies that address the contributing factors of cardiovascular dysfunction ...
Ivana Y. Kuo, A. Chapman
semanticscholar +4 more sources
Introduction Autosomal dominant polycystic kidney disease (ADPKD) is a multisystem syndrome associated with significant morbidity and mortality, particularly kidney failure.
Julia Jefferis +7 more
doaj +2 more sources
Myofibroblast- specific autophagy drives cyst growth in autosomal dominant polycystic kidney disease [PDF]
Background Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive cyst expansion, fibrosis and inflammation, leading to kidney failure. Myofibroblasts (MFs) often accumulate around cysts and promote fibrosis and cyst growth,
Abeda Jamadar +9 more
doaj +2 more sources
ADPKD current management and ongoing trials [PDF]
Among the diseases that require renal replacement therapy (RRT), ADPKD is the fourth for incidence and prevalence. In Italy, there are at least 32,000 patients affected by ADPKD, of which about 2900 in dialysis.
F. Testa, R. Magistroni
semanticscholar +2 more sources
A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model [PDF]
Background Autosomal dominant polycystic kidney disease (ADPKD) is the leading inheritable cause of end-stage renal disease (ESRD); however, the natural course of disease progression is heterogeneous between patients.
Phil McEwan +9 more
doaj +8 more sources
Safety and feasibility of synchronous unilateral nephrectomy and contralateral heminephrectomy for extremely severe autosomal dominant polycystic kidney disease: Techniques and outcome [PDF]
Purpose: To demonstrate the safety and feasibility of synchronous unilateral nephrectomy and contralateral heminephrectomy in extremely severe autosomal dominant polycystic kidney disease (ADPKD), which corresponds to the Mayo imaging classification ...
Jang Hee Han +7 more
doaj +1 more source
[Molecular diagnosis of ADPKD].
Most patients with ADPKD do not need molecular genetic testing. When indicated, Sanger sequencing is the most commonly used technique. When a pathogenic mutation is not identified by Sanger, multiplex ligation-dependent probe amplification analysis (MLPA) should be performed to detect gene rearrangement (insertion or deletion).
SCOLARI, Francesco +3 more
openaire +3 more sources

